Viatris Financial News

10.08 / 17:19

COST CEO Viatris country Biocon Q1 Results: Profit drops 30% YoY to Rs 101 crore, revenue jumps 59%

Biocon on Thursday reported 30‰ year-on-year (YoY) drop in net profit to Rs 101 crore for the quarter ended June 2023. The company had reported net profit of Rs 144 crore during corresponding quarter of the previous year. The company attributed the drop in net profit to depreciation, amortisation and interest increase of Rs 353 crore over last year primarily related to the biosimilar business acquisition cost.

08.08 / 06:37

UPS Provident Viatris fall Sovos Brands, Elanco Animal Health rise; Tyson Foods, Gogo fall, Monday, 8/7/2023

Stocks that traded heavily or had substantial price changes on Monday: Sovos Brands, Elanco Animal Health rise; Tyson Foods, Gogo fall

08.08 / 06:37

COMPOSITE SENSEX Nikkei Viatris KOSPI show Stock market today: Asia mixed after Wall St rallies ahead of US inflation update

Asian stocks are mixed after Wall Street rallied and Japanese wages rose ahead of a U.S. inflation update that might influence Federal Reserve plans for possible interest rate hikes

07.08 / 16:21

PayPal Tesla BioNTech Viatris track Stocks making the biggest moves midday: Tesla, Berkshire Hathaway, PayPal, Cinemark and more

In this article

07.08 / 12:47

BioNTech UBS Viatris pop Stocks making the biggest moves premarket: Sovos Brands, BioNTech, Tyson Foods and more

In this article

06.07 / 18:35

UPS Waves Booking Monolithic Viatris ‘Biocon Biologics ahead of plan in integrating Viatris’

MUMBAI : Biocon Biologics Ltd, the biosimilar unit of drugmaker Biocon Ltd, has achieved a third of its post-deal integration with Viatris’s global biosimilar portfolio ahead of time and expects to focus on integrating its US and European operations in the next phase, chief executive Shreehas Tambe said, adding the company also expects to raise additional capital this year. “Earlier, we had guided two years for the whole transition. A good part is the first wave has come way ahead of plan and is a good indicator of where we are headed," Tambe said.

05.07 / 15:01

UPS Waves CEO Viatris Biocon Biologics takes over Viatris' biosimilar biz in over 70 countries

Biocon Biologics on Wednesday said it has completed the integration of the acquired biosimilars business from Viatris Inc in over 70 countries in emerging markets effective July 1, 2023, increasing the scale and scope of its business. Following the deal closure in November 2022, this marks the first wave of countries where Viatris' operations have fully transitioned to Biocon Biologics, the company said in a statement.

08.05 / 17:35

UPS JPMorgan Airlines Occidental Fortinet Viatris PacWest Stocks making the biggest moves midday: Berkshire Hathaway, Catalent, Tyson Foods, Zscaler and more

In this article

08.05 / 12:25

UPS Airlines Occidental Zions Fortinet Viatris PacWest American Airlines Stocks making the biggest premarket moves: PacWest, Berkshire Hathaway, American Airlines, AMC and more

In this article

27.02 / 20:25

Target McDonald's CEO JPMorgan Tesla Albemarle Viatris Stocks making the biggest moves midday: Union Pacific, Fisker, Tesla, Zillow and more

Check out the companies making headlines in midday trading.

what you should know about Viatris

What is Viatris and why is it gaining attention?

Viatris is a significant category that is in the spotlight. On our site, we regularly publish news related to this subject.

Where can I find the latest updates on Viatris?

All latest articles about Viatris can be found in the highlighted block. We publish information regularly.

How can I verify the accuracy of information on Viatris?

We consult with professionals to ensure that the information about Viatris is accurate and valuable for our readers.